List of Tables
Table 1. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of SGD-2083
Table 3. Key Players of Crizanlizumab
Table 4. Key Players of PF-04447943
Table 5. Key Players of NVX-508
Table 6. Key Players of Others
Table 7. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region (2020-2025)
Table 11. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region (2026-2031)
Table 13. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Trends
Table 14. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Drivers
Table 15. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Challenges
Table 16. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Restraints
Table 17. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Players (2020-2025)
Table 19. Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug as of 2024)
Table 20. Ranking of Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug, Headquarters and Area Served
Table 23. Global Key Players of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug, Product and Application
Table 24. Global Key Players of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. AstraZeneca Plc Company Details
Table 50. AstraZeneca Plc Business Overview
Table 51. AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 52. AstraZeneca Plc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 53. AstraZeneca Plc Recent Development
Table 54. Bristol-Myers Squibb Company Company Details
Table 55. Bristol-Myers Squibb Company Business Overview
Table 56. Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 57. Bristol-Myers Squibb Company Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 58. Bristol-Myers Squibb Company Recent Development
Table 59. Gilead Sciences Inc Company Details
Table 60. Gilead Sciences Inc Business Overview
Table 61. Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 62. Gilead Sciences Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 63. Gilead Sciences Inc Recent Development
Table 64. Modus Therapeutics Holding AB Company Details
Table 65. Modus Therapeutics Holding AB Business Overview
Table 66. Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 67. Modus Therapeutics Holding AB Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 68. Modus Therapeutics Holding AB Recent Development
Table 69. Novartis AG Company Details
Table 70. Novartis AG Business Overview
Table 71. Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 72. Novartis AG Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. NuvOx Pharma LLC Company Details
Table 75. NuvOx Pharma LLC Business Overview
Table 76. NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 77. NuvOx Pharma LLC Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 78. NuvOx Pharma LLC Recent Development
Table 79. Pfizer Inc Company Details
Table 80. Pfizer Inc Business Overview
Table 81. Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 82. Pfizer Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 83. Pfizer Inc Recent Development
Table 84. Seattle Genetics Inc Company Details
Table 85. Seattle Genetics Inc Business Overview
Table 86. Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product
Table 87. Seattle Genetics Inc Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025) & (US$ Million)
Table 88. Seattle Genetics Inc Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Picture
Figure 2. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Type: 2024 VS 2031
Figure 4. SGD-2083 Features
Figure 5. Crizanlizumab Features
Figure 6. PF-04447943 Features
Figure 7. NVX-508 Features
Figure 8. Others Features
Figure 9. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Application: 2024 VS 2031
Figure 11. Clinic Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Report Years Considered
Figure 15. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Players in 2024
Figure 19. Global Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in 2024
Figure 21. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2020-2031)
Figure 23. United States Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2020-2031)
Figure 27. Germany Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Region (2020-2031)
Figure 35. China Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2020-2031)
Figure 43. Mexico Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share by Country (2020-2031)
Figure 47. Turkey Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AstraZeneca Plc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 51. Bristol-Myers Squibb Company Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 52. Gilead Sciences Inc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 53. Modus Therapeutics Holding AB Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 54. Novartis AG Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 55. NuvOx Pharma LLC Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 56. Pfizer Inc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 57. Seattle Genetics Inc Revenue Growth Rate in Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
